Upstream and Downstream Bioprocessing - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510240826

Publication Date:

October 14, 2024

Pages:

111

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Upstream and Downstream Bioprocessing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Upstream and Downstream Bioprocessing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Upstream and Downstream Bioprocessing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Upstream and Downstream Bioprocessing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Upstream and Downstream Bioprocessing include Danaher, Eppendorf, GE Healthcare, Parker Hannifin, Thermo Fisher Scientific, Corning, Merck, Lonza- Pharma & Biotech and Boehringer Ingelheim Pharma GmbH & Co.KG,, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Upstream and Downstream Bioprocessing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Upstream and Downstream Bioprocessing by region & country, by Type, and by Application.
The Upstream and Downstream Bioprocessing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Upstream and Downstream Bioprocessing.
麻豆原创 Segmentation
By Company
Danaher
Eppendorf
GE Healthcare
Parker Hannifin
Thermo Fisher Scientific
Corning
Merck
Lonza- Pharma & Biotech
Boehringer Ingelheim Pharma GmbH & Co.KG,
BiOZEEN
Katalyst Bio Engineering
ABEC Biopharmaceutical Manufacturing
Bionet Engineering
Segment by Type:
Upstream Bioprocessing
Downstream Bioprocessing
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Upstream and Downstream Bioprocessing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Upstream and Downstream Bioprocessing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Upstream and Downstream Bioprocessing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Upstream and Downstream Bioprocessing Product Introduction
1.2 Global Upstream and Downstream Bioprocessing 麻豆原创 Size Forecast
1.3 Upstream and Downstream Bioprocessing 麻豆原创 Trends & Drivers
1.3.1 Upstream and Downstream Bioprocessing Industry Trends
1.3.2 Upstream and Downstream Bioprocessing 麻豆原创 Drivers & Opportunity
1.3.3 Upstream and Downstream Bioprocessing 麻豆原创 Challenges
1.3.4 Upstream and Downstream Bioprocessing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Upstream and Downstream Bioprocessing Players Revenue Ranking (2023)
2.2 Global Upstream and Downstream Bioprocessing Revenue by Company (2019-2024)
2.3 Key Companies Upstream and Downstream Bioprocessing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Upstream and Downstream Bioprocessing Product Offered
2.5 Key Companies Time to Begin Mass Production of Upstream and Downstream Bioprocessing
2.6 Upstream and Downstream Bioprocessing 麻豆原创 Competitive Analysis
2.6.1 Upstream and Downstream Bioprocessing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Upstream and Downstream Bioprocessing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Upstream and Downstream Bioprocessing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Upstream Bioprocessing
3.1.2 Downstream Bioprocessing
3.2 Global Upstream and Downstream Bioprocessing Sales Value by Type
3.2.1 Global Upstream and Downstream Bioprocessing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Upstream and Downstream Bioprocessing Sales Value, by Type (2019-2030)
3.2.3 Global Upstream and Downstream Bioprocessing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Biotechnology
4.1.3 Academic and Research Institutes
4.1.4 Others
4.2 Global Upstream and Downstream Bioprocessing Sales Value by Application
4.2.1 Global Upstream and Downstream Bioprocessing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Upstream and Downstream Bioprocessing Sales Value, by Application (2019-2030)
4.2.3 Global Upstream and Downstream Bioprocessing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Upstream and Downstream Bioprocessing Sales Value by Region
5.1.1 Global Upstream and Downstream Bioprocessing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Upstream and Downstream Bioprocessing Sales Value by Region (2019-2024)
5.1.3 Global Upstream and Downstream Bioprocessing Sales Value by Region (2025-2030)
5.1.4 Global Upstream and Downstream Bioprocessing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Upstream and Downstream Bioprocessing Sales Value, 2019-2030
5.2.2 North America Upstream and Downstream Bioprocessing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Upstream and Downstream Bioprocessing Sales Value, 2019-2030
5.3.2 Europe Upstream and Downstream Bioprocessing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Upstream and Downstream Bioprocessing Sales Value, 2019-2030
5.4.2 Asia Pacific Upstream and Downstream Bioprocessing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Upstream and Downstream Bioprocessing Sales Value, 2019-2030
5.5.2 South America Upstream and Downstream Bioprocessing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Upstream and Downstream Bioprocessing Sales Value, 2019-2030
5.6.2 Middle East & Africa Upstream and Downstream Bioprocessing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Upstream and Downstream Bioprocessing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Upstream and Downstream Bioprocessing Sales Value
6.3 United States
6.3.1 United States Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.3.2 United States Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.4.2 Europe Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.5.2 China Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.6.2 Japan Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.7.2 South Korea Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.8.2 Southeast Asia Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Upstream and Downstream Bioprocessing Sales Value, 2019-2030
6.9.2 India Upstream and Downstream Bioprocessing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Upstream and Downstream Bioprocessing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Danaher
7.1.1 Danaher Profile
7.1.2 Danaher Main Business
7.1.3 Danaher Upstream and Downstream Bioprocessing Products, Services and Solutions
7.1.4 Danaher Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.1.5 Danaher Recent Developments
7.2 Eppendorf
7.2.1 Eppendorf Profile
7.2.2 Eppendorf Main Business
7.2.3 Eppendorf Upstream and Downstream Bioprocessing Products, Services and Solutions
7.2.4 Eppendorf Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.2.5 Eppendorf Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Upstream and Downstream Bioprocessing Products, Services and Solutions
7.3.4 GE Healthcare Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.3.5 Parker Hannifin Recent Developments
7.4 Parker Hannifin
7.4.1 Parker Hannifin Profile
7.4.2 Parker Hannifin Main Business
7.4.3 Parker Hannifin Upstream and Downstream Bioprocessing Products, Services and Solutions
7.4.4 Parker Hannifin Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.4.5 Parker Hannifin Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Upstream and Downstream Bioprocessing Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Corning
7.6.1 Corning Profile
7.6.2 Corning Main Business
7.6.3 Corning Upstream and Downstream Bioprocessing Products, Services and Solutions
7.6.4 Corning Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.6.5 Corning Recent Developments
7.7 Merck
7.7.1 Merck Profile
7.7.2 Merck Main Business
7.7.3 Merck Upstream and Downstream Bioprocessing Products, Services and Solutions
7.7.4 Merck Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.7.5 Merck Recent Developments
7.8 Lonza- Pharma & Biotech
7.8.1 Lonza- Pharma & Biotech Profile
7.8.2 Lonza- Pharma & Biotech Main Business
7.8.3 Lonza- Pharma & Biotech Upstream and Downstream Bioprocessing Products, Services and Solutions
7.8.4 Lonza- Pharma & Biotech Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.8.5 Lonza- Pharma & Biotech Recent Developments
7.9 Boehringer Ingelheim Pharma GmbH & Co.KG,
7.9.1 Boehringer Ingelheim Pharma GmbH & Co.KG, Profile
7.9.2 Boehringer Ingelheim Pharma GmbH & Co.KG, Main Business
7.9.3 Boehringer Ingelheim Pharma GmbH & Co.KG, Upstream and Downstream Bioprocessing Products, Services and Solutions
7.9.4 Boehringer Ingelheim Pharma GmbH & Co.KG, Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.9.5 Boehringer Ingelheim Pharma GmbH & Co.KG, Recent Developments
7.10 BiOZEEN
7.10.1 BiOZEEN Profile
7.10.2 BiOZEEN Main Business
7.10.3 BiOZEEN Upstream and Downstream Bioprocessing Products, Services and Solutions
7.10.4 BiOZEEN Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.10.5 BiOZEEN Recent Developments
7.11 Katalyst Bio Engineering
7.11.1 Katalyst Bio Engineering Profile
7.11.2 Katalyst Bio Engineering Main Business
7.11.3 Katalyst Bio Engineering Upstream and Downstream Bioprocessing Products, Services and Solutions
7.11.4 Katalyst Bio Engineering Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.11.5 Katalyst Bio Engineering Recent Developments
7.12 ABEC Biopharmaceutical Manufacturing
7.12.1 ABEC Biopharmaceutical Manufacturing Profile
7.12.2 ABEC Biopharmaceutical Manufacturing Main Business
7.12.3 ABEC Biopharmaceutical Manufacturing Upstream and Downstream Bioprocessing Products, Services and Solutions
7.12.4 ABEC Biopharmaceutical Manufacturing Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.12.5 ABEC Biopharmaceutical Manufacturing Recent Developments
7.13 Bionet Engineering
7.13.1 Bionet Engineering Profile
7.13.2 Bionet Engineering Main Business
7.13.3 Bionet Engineering Upstream and Downstream Bioprocessing Products, Services and Solutions
7.13.4 Bionet Engineering Upstream and Downstream Bioprocessing Revenue (US$ Million) & (2019-2024)
7.13.5 Bionet Engineering Recent Developments
8 Industry Chain Analysis
8.1 Upstream and Downstream Bioprocessing Industrial Chain
8.2 Upstream and Downstream Bioprocessing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Upstream and Downstream Bioprocessing Sales Model
8.5.2 Sales Channel
8.5.3 Upstream and Downstream Bioprocessing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Danaher
Eppendorf
GE Healthcare
Parker Hannifin
Thermo Fisher Scientific
Corning
Merck
Lonza- Pharma & Biotech
Boehringer Ingelheim Pharma GmbH & Co.KG,
BiOZEEN
Katalyst Bio Engineering
ABEC Biopharmaceutical Manufacturing
Bionet Engineering

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.